期刊文献+

HBV对HepG2.2.15细胞α干扰素的JAK-STAT信号转导途径分子及MxA mRNA表达的影响 被引量:8

The influence of HBV on the expression of interferon-α JAK-STAT signal transductive pathway molecules and MxA mRNA in HepG2.2.15 cells
下载PDF
导出
摘要 目的研究乙型肝炎病毒(HBV)对α干扰素(IFN-α)JAK-STAT信号转导途径分子及MxAmRNA表达的影响。方法逆转录聚合酶链反应(RT-PCR)检测IFN-α处理的HepG2.2.15细胞在不同处理时间点的STAT1、STAT2、IS-GF3γmRNA表达水平,并比较分析干扰素抗病毒蛋白MxAmRNA在HepG2和HepG2.2.15细胞中的表达。结果RT-PCR显示经IFN-α处理后HepG2.2.15细胞STAT1、STAT2、ISGF3γmRNA表达水平明显升高,表明转染HBV全基因组并能分泌完整HBV病毒子的HepG2.2.15对IFN-α有应答。抗病毒蛋白MxAmRNA在HepG2.2.15细胞中未检测到表达,而在HepG2细胞中却能表达。结论HBV或其抗原成分并不影响IFN-αJAK-STAT信号转导途径分子mRNA表达,但影响抗病毒蛋白如MxAmRNA的表达。 Objective To investigate the influence of HBV on the expression of interferon-α JAK-STAT signal transductive pathway molecules and MxA mRNA in HepG2.2.15 cells.Methods The expression levels of STAT1,STAT2,ISGF3γ mRNA in HepG2.2.15 cells at different time points were detected by reversing transcription polymerase chain reaction (RT-PCR),and the analysis of the expression levels of MxA mRNAs between in HepG2 and HepG2.2.15 cells was performed.Results RT-PCR showed that the expression levels of the STAT1,STAT2,ISGF3γ mRNAs in HepG2.2.15 cells which treated with IFN-α increased significantly,which suggested that the HBV stably-transfected HepG2.2.15 could response to IFN-α.Also,it was found,in this research,HepG2.2.15 cells were unable to express the MxA mRNA at detectedable levels,while it could be expressed in HepG2 cells.Conclusion HBV and its antigen components don′t affect the signal transductive pathway molecules mRNA of JAK-STAT but inhibit the anti-viral proteins mRNA expression,such as the MxA,in HepG2.2.15 cells.
出处 《安徽医科大学学报》 CAS 北大核心 2010年第2期153-156,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:30600522) 安徽省教育厅自然科学基金(编号:2006KJ308B)
关键词 肝炎病毒 乙型 干扰素Α hepatitis B virus interferon-α
  • 相关文献

参考文献4

二级参考文献38

  • 1张全干.苦参素注射液治疗慢性乙型肝炎36例临床观察[J].广西医学,2005,27(9):1450-1451. 被引量:2
  • 2齐青松,陈仕彬,杨茜,易冬英.拉米夫定治疗慢性乙肝的疗效及乙肝病毒YMDD变异的研究[J].江西医学院学报,2005,45(5):42-45. 被引量:8
  • 3曾卫新,谭荣欣,尹燕耀.派罗欣治疗慢性乙肝18例临床观察[J].实用临床医学(江西),2005,6(12):36-38. 被引量:11
  • 4李霖,李玉珍.抗乙肝病毒新药——恩替卡韦[J].临床药物治疗杂志,2006,4(4):56-58. 被引量:30
  • 5Chisari FV, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice.Cell, 1989, 59: 1145-1156.
  • 6Evans AA, Fine M, London WT. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J Infect Dis, 1997, 176: 845-850.
  • 7Sells MA, Chen ML, Acs G. Production of hepatitis B virius particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA, 1987, 84: 1005-1009.
  • 8Marshall A, Hodgson J. DNA chips: an array of possibilities. Nat Biotechnol, 1998, 16: 27-31.
  • 9Schlaak JF, Hilkens CM, Costa-Pereira AP, et al. Cell-tape and donor-specific transcriptional responses to interferon-α. J Biol Chem,2002, 277: 49428-49437.
  • 10Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev,2001, 14: 778-809.

共引文献30

同被引文献75

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部